The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

“Vertex’s 2024 financial results demonstrated ... businesses using native enterprise resource planning (“ERP”) functions to switch to our software; our ability to accurately forecast ...

Google Cloud's Vertex AI Search for Healthcare tool is ... to find the information they need using Google's familiar search function and gen AI. The company said the new Vertex AI Search features ...

Out of six evaluable patients on that dose, four achieved remission and stable kidney function. A higher 240 mg dose achieved similar results. Vertex’s move for Alpine marks a turnaround in the ...

Navina, a clinical intelligence company, closed a $55 million Series C funding round. The round was led by a division of ...

At Vertex, I’ve known Duncan 30 years ... high enough returning CFTR function to where it would be in a patient who didn’t have CF then we’ll be able to sort of prevent the manifestations ...

A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis ... or one F508del copy and one of 14 other so-called “minimal function” mutations in CFTR. The new EU approval ...

Google is doubling down on building out its AI business in the U.K. On Monday morning in London, the CEO of Google DeepMind, ...